Medical devices, healthcare technology and the business of care
510(k) clearance · K262516

TSK OptiXion

Tsk Laboratory, Japan · Decision date Oct 6, 2026

MEDTECHLEDGER EXPLANATIONK262516

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for TSK OptiXion, a traditional 510(k) submitted by Tsk Laboratory, Japan, under 510(k) number K262516. The decision date is 2026-10-06; the application was received 07/21/2026. The device is listed under the classification name Ophthalmic Needle, regulation number 880.5570, with classification product code QYM and subsequent product codes FMI and QNS. The regulation medical specialty and review panel are both General Hospital.

SESE indicates clearance to market as substantially equivalent to a predicate device; it is not premarket approval of a new device. The record shows the review was not conducted by a third party, the product is not a combination product, and no predetermined change control plan was authorized. The public record does not identify the predicate device, the specific components or changes assessed, or the basis for the equivalence determination, so those details remain unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Oct 6, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262516
Regulatory pathway
510(k) premarket notification
Product code
QYM
Decision code
SESE
Decision date
Oct 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ophthalmic Needle.

Product code
QYM
FDA device class
2

FDA decision timeline

  1. K262516 received

    Application receipt date recorded by FDA.

  2. K262516 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Tsk Laboratory, Japan

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tochigi-Ken

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records